MK-677 'definitely recommend': what the science actually says

What did @dawid.1212 actually say?

Honestly? It's hard to tell. The transcript from this 513,000-view TikTok is almost entirely incoherent, likely the result of auto-captioning failure or background audio interference. The only legible signal is the caption itself: "Mk677 definitely would recommend." That's the claim we're fact-checking, because it's the one half a million people actually received.

The video sits under a peptide therapy hashtag, so the implicit message is clear: MK-677 is worth taking. No dosage, no context, no caveats. Just a thumbs-up for a compound that the FDA has never approved for human use and that carries a genuinely complicated risk profile. That's worth unpacking.

Does the science back up a blanket recommendation?

No. MK-677 (ibutamoren) does increase growth hormone and IGF-1 levels, and that part is well-documented. But "increases GH" is not the same as "safe and effective for whatever you're hoping it does." The evidence base is narrow, the side effect profile is real, and a flat recommendation ignores all of that.

A 2008 randomized controlled trial by Nass et al. in the Journal of Clinical Endocrinology and Metabolism found MK-677 increased IGF-1 in older adults but also raised fasting blood glucose and worsened insulin resistance. A 1998 study by Chapman et al. in the same journal confirmed GH pulse amplification, but participants experienced increased appetite, edema, and muscle pain. More recently, a 2023 review by Sigalos and Pastuszak in Sexual Medicine Reviews noted that long-term safety data in healthy adults is essentially absent. "Definitely recommend" based on that evidence base is not a responsible position.

What did they get wrong, or right?

They got the enthusiasm wrong. MK-677 has legitimate research interest, particularly in muscle wasting conditions and GH deficiency in older adults. Giving it an unqualified recommendation to a general TikTok audience, without acknowledging insulin resistance risk, potential for elevated cortisol, or the complete absence of FDA approval, is misleading by omission.

To be fair, MK-677 is not a steroid, and it does not suppress endogenous testosterone the way anabolic steroids do. That distinction matters and sometimes gets lost in online discourse. But the "no sides, all gains" framing that short-form peptide content often implies, including this video's caption, flattens a compound that genuinely requires medical supervision to use responsibly.

• MK-677 is not approved by the FDA for any indication.
• It is banned by WADA for competitive athletes.
• It has been linked to increased fasting glucose in clinical trials.
• It is sometimes sold as a research chemical, with no quality controls.

What should you actually know?

MK-677 works by mimicking ghrelin and stimulating the pituitary to release growth hormone. It's oral, which makes it appealing compared to injectable peptides. But "oral and convenient" does not mean low-risk. The insulin resistance signal from clinical trials is not minor, especially for anyone with prediabetes or metabolic syndrome.

If you're interested in peptide therapy for recovery, body composition, or longevity, that's a legitimate conversation to have with a licensed provider who can assess your baseline IGF-1, fasting glucose, and overall metabolic health. A TikTok caption is not that conversation. The compound may have a role in supervised, individualized protocols. What it does not have is a clean enough evidence base to support a general public recommendation with zero qualifiers.